Total: £ 56.28
Published Date: 2026-05-15 | Pages: 95 | Tables: 91 | Pharma & Healthcare
The global Mirogabalin Besilate Tablets market was valued at US$ 490 million in 2025 and is anticipated to reach US$ 1184 million by 2032, at a CAGR of 12.0% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Mirogabalin Besilate Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Mirogabalin Besilate Tablets Is A Novel, Selective, And Centrally Acting Analgesic Agent, Which Mainly Acts On The Voltage-Gated Calcium Channels In The Central Nervous System. It Can Effectively Reduce The Release Of Pain-Related Neurotransmitters, Improve Abnormal Nerve Signal Transmission, And Is Clinically Mainly Indicated For The Treatment Of Peripheral Neuropathic Pain In Adult Patients. With High Analgesic Efficiency And Good Tolerability, This Drug Has Become An Important Therapeutic Option For Chronic Neuralgia Diseases.n 2025, global Mirogabalin Besilate Tablets production reached approximately 4,000,000 bottles.
Mirogabalin Besylate Tablets are a novel central analgesic agent, primarily indicated for the treatment of diabetic peripheral neuropathic pain in adults. With a unique pharmacological mechanism of action, it fills the gap in the relevant clinical treatment field.
Classified as a third-generation calcium channel modulator, this drug boasts steady analgesic efficacy, favorable tolerability and a low incidence of adverse reactions compared with conventional analgesics. It is better suited to the long-term treatment needs of patients with chronic neuralgia and has gained wide recognition in clinical practice.
From the perspective of market demand, the high prevalence of underlying diseases has resulted in a sustained patient population with related painful conditions. The growing clinical demand for safe and innovative analgesic drugs has laid a solid foundation for the market development of this product.
At present, the market is dominated by the original branded drug, while multiple pharmaceutical enterprises have launched the research and development of generic versions, forming a competitive landscape led by the original drug with generics in active pursuit.
Supported by medical insurance policies, improved clinical accessibility and the gradual launch of generic drugs, its market coverage will be further expanded. Meanwhile, the product will face intensified market competition. Its future market development will focus on the enhancement of clinical value, optimization of channel distribution and differentiated product competition
This report delivers a comprehensive overview of the global Mirogabalin Besilate Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Mirogabalin Besilate Tablets. The Mirogabalin Besilate Tablets market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Mirogabalin Besilate Tablets market comprehensively. Regional market sizes by Type, by Application, by Production Technology, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Mirogabalin Besilate Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Daiichi Sankyo
Jiangsu Lianhuan Pharmaceutical
Chongqing Huabang Pharmaceutical
Shandong Jingwei Pharmaceutical
Hainan Herui Pharmaceutical
Segment by Type
2.5mg
5mg
Segment by Production Technology
Original
Generic
Segment by Combination Therapy
Mirogabalin Besylate + Mecobalamin
Mirogabalin Besylate + Duloxetine
by Application
Diabetic Peripheral Neuropathic Pain
Postherpetic Neuralgia
Fibromyalgia Syndrome
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Production Technology, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Mirogabalin Besilate Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Mirogabalin Besilate Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Mirogabalin Besilate Tablets Market Overview
1.1 Product Definition
1.2 Mirogabalin Besilate Tablets by Type
1.2.1 Global Mirogabalin Besilate Tablets Market Value by Type: 2025 vs 2032
1.2.2 2.5mg
1.2.3 5mg
1.3 Mirogabalin Besilate Tablets by Production Technology
1.3.1 Global Mirogabalin Besilate Tablets Market Value by Production Technology: 2025 vs 2032
1.3.2 Original
1.3.3 Generic
1.4 Mirogabalin Besilate Tablets by Combination Therapy
1.4.1 Global Mirogabalin Besilate Tablets Market Value by Combination Therapy: 2025 vs 2032
1.4.2 Mirogabalin Besylate + Mecobalamin
1.4.3 Mirogabalin Besylate + Duloxetine
1.5 Mirogabalin Besilate Tablets by Application
1.5.1 Global Mirogabalin Besilate Tablets Market Value by Application: 2025 vs 2032
1.5.2 Diabetic Peripheral Neuropathic Pain
1.5.3 Postherpetic Neuralgia
1.5.4 Fibromyalgia Syndrome
1.5.5 Others
1.6 Global Mirogabalin Besilate Tablets Market Size Estimates and Forecasts
1.6.1 Global Mirogabalin Besilate Tablets Revenue 2021–2032
1.6.2 Global Mirogabalin Besilate Tablets Sales 2021–2032
1.6.3 Global Mirogabalin Besilate Tablets Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Mirogabalin Besilate Tablets Market Competition by Manufacturers
2.1 Global Mirogabalin Besilate Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Mirogabalin Besilate Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Mirogabalin Besilate Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Mirogabalin Besilate Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Mirogabalin Besilate Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Mirogabalin Besilate Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Mirogabalin Besilate Tablets, Date of Entry into the Industry
2.8 Global Mirogabalin Besilate Tablets Market Competitive Situation and Trends
2.8.1 Global Mirogabalin Besilate Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Mirogabalin Besilate Tablets Players Market Share by Revenue
2.8.3 Global Mirogabalin Besilate Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mirogabalin Besilate Tablets Market Scenario by Region
3.1 Global Mirogabalin Besilate Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Mirogabalin Besilate Tablets Sales by Region: 2021–2032
3.2.1 Global Mirogabalin Besilate Tablets Sales by Region: 2021–2026
3.2.2 Global Mirogabalin Besilate Tablets Sales by Region: 2027–2032
3.3 Global Mirogabalin Besilate Tablets Revenue by Region: 2021–2032
3.3.1 Global Mirogabalin Besilate Tablets Revenue by Region: 2021–2026
3.3.2 Global Mirogabalin Besilate Tablets Revenue by Region: 2027–2032
3.4 North America Mirogabalin Besilate Tablets Market Facts & Figures by Country
3.4.1 North America Mirogabalin Besilate Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Mirogabalin Besilate Tablets Sales by Country (2021–2032)
3.4.3 North America Mirogabalin Besilate Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mirogabalin Besilate Tablets Market Facts & Figures by Country
3.5.1 Europe Mirogabalin Besilate Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Mirogabalin Besilate Tablets Sales by Country (2021–2032)
3.5.3 Europe Mirogabalin Besilate Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mirogabalin Besilate Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Mirogabalin Besilate Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Mirogabalin Besilate Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Mirogabalin Besilate Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mirogabalin Besilate Tablets Market Facts & Figures by Country
3.7.1 Latin America Mirogabalin Besilate Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Mirogabalin Besilate Tablets Sales by Country (2021–2032)
3.7.3 Latin America Mirogabalin Besilate Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mirogabalin Besilate Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Mirogabalin Besilate Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Mirogabalin Besilate Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Mirogabalin Besilate Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mirogabalin Besilate Tablets Sales by Type (2021–2032)
4.1.1 Global Mirogabalin Besilate Tablets Sales by Type (2021–2026)
4.1.2 Global Mirogabalin Besilate Tablets Sales by Type (2027–2032)
4.1.3 Global Mirogabalin Besilate Tablets Sales Market Share by Type (2021–2032)
4.2 Global Mirogabalin Besilate Tablets Revenue by Type (2021–2032)
4.2.1 Global Mirogabalin Besilate Tablets Revenue by Type (2021–2026)
4.2.2 Global Mirogabalin Besilate Tablets Revenue by Type (2027–2032)
4.2.3 Global Mirogabalin Besilate Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Mirogabalin Besilate Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Mirogabalin Besilate Tablets Sales by Application (2021–2032)
5.1.1 Global Mirogabalin Besilate Tablets Sales by Application (2021–2026)
5.1.2 Global Mirogabalin Besilate Tablets Sales by Application (2027–2032)
5.1.3 Global Mirogabalin Besilate Tablets Sales Market Share by Application (2021–2032)
5.2 Global Mirogabalin Besilate Tablets Revenue by Application (2021–2032)
5.2.1 Global Mirogabalin Besilate Tablets Revenue by Application (2021–2026)
5.2.2 Global Mirogabalin Besilate Tablets Revenue by Application (2027–2032)
5.2.3 Global Mirogabalin Besilate Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Mirogabalin Besilate Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Daiichi Sankyo
6.1.1 Daiichi Sankyo Company Information
6.1.2 Daiichi Sankyo Description and Business Overview
6.1.3 Daiichi Sankyo Mirogabalin Besilate Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Daiichi Sankyo Mirogabalin Besilate Tablets Product Portfolio
6.1.5 Daiichi Sankyo Recent Developments/Updates
6.2 Jiangsu Lianhuan Pharmaceutical
6.2.1 Jiangsu Lianhuan Pharmaceutical Company Information
6.2.2 Jiangsu Lianhuan Pharmaceutical Description and Business Overview
6.2.3 Jiangsu Lianhuan Pharmaceutical Mirogabalin Besilate Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Jiangsu Lianhuan Pharmaceutical Mirogabalin Besilate Tablets Product Portfolio
6.2.5 Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates
6.3 Chongqing Huabang Pharmaceutical
6.3.1 Chongqing Huabang Pharmaceutical Company Information
6.3.2 Chongqing Huabang Pharmaceutical Description and Business Overview
6.3.3 Chongqing Huabang Pharmaceutical Mirogabalin Besilate Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Chongqing Huabang Pharmaceutical Mirogabalin Besilate Tablets Product Portfolio
6.3.5 Chongqing Huabang Pharmaceutical Recent Developments/Updates
6.4 Shandong Jingwei Pharmaceutical
6.4.1 Shandong Jingwei Pharmaceutical Company Information
6.4.2 Shandong Jingwei Pharmaceutical Description and Business Overview
6.4.3 Shandong Jingwei Pharmaceutical Mirogabalin Besilate Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Shandong Jingwei Pharmaceutical Mirogabalin Besilate Tablets Product Portfolio
6.4.5 Shandong Jingwei Pharmaceutical Recent Developments/Updates
6.5 Hainan Herui Pharmaceutical
6.5.1 Hainan Herui Pharmaceutical Company Information
6.5.2 Hainan Herui Pharmaceutical Description and Business Overview
6.5.3 Hainan Herui Pharmaceutical Mirogabalin Besilate Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Hainan Herui Pharmaceutical Mirogabalin Besilate Tablets Product Portfolio
6.5.5 Hainan Herui Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mirogabalin Besilate Tablets Industry Chain Analysis
7.2 Mirogabalin Besilate Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mirogabalin Besilate Tablets Production Mode & Process Analysis
7.4 Mirogabalin Besilate Tablets Sales and Marketing
7.4.1 Mirogabalin Besilate Tablets Sales Channels
7.4.2 Mirogabalin Besilate Tablets Distributors
7.5 Mirogabalin Besilate Tablets Customer Analysis
8 Mirogabalin Besilate Tablets Market Dynamics
8.1 Mirogabalin Besilate Tablets Industry Trends
8.2 Mirogabalin Besilate Tablets Market Drivers
8.3 Mirogabalin Besilate Tablets Market Challenges
8.4 Mirogabalin Besilate Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Mirogabalin Besilate Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Mirogabalin Besilate Tablets Market Value by Production Technology (US$ Million), 2025 vs 2032
Table 3. Global Mirogabalin Besilate Tablets Market Value by Combination Therapy (US$ Million), 2025 vs 2032
Table 4. Global Mirogabalin Besilate Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Mirogabalin Besilate Tablets Market Competitive Situation by Manufacturers in 2025
Table 6. Global Mirogabalin Besilate Tablets Sales (Units) of Key Manufacturers (2021–2026)
Table 7. Global Mirogabalin Besilate Tablets Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Mirogabalin Besilate Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Mirogabalin Besilate Tablets Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Mirogabalin Besilate Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Mirogabalin Besilate Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Mirogabalin Besilate Tablets, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Mirogabalin Besilate Tablets, Product Types and Applications
Table 14. Global Key Manufacturers of Mirogabalin Besilate Tablets, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Mirogabalin Besilate Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Mirogabalin Besilate Tablets Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Mirogabalin Besilate Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Mirogabalin Besilate Tablets Sales by Region (Units), 2021–2026
Table 20. Global Mirogabalin Besilate Tablets Sales Market Share by Region (2021–2026)
Table 21. Global Mirogabalin Besilate Tablets Sales by Region (Units), 2027–2032
Table 22. Global Mirogabalin Besilate Tablets Sales Market Share by Region (2027–2032)
Table 23. Global Mirogabalin Besilate Tablets Revenue by Region (US$ Million), 2021–2026
Table 24. Global Mirogabalin Besilate Tablets Revenue Market Share by Region (2021–2026)
Table 25. Global Mirogabalin Besilate Tablets Revenue by Region (US$ Million), 2027–2032
Table 26. Global Mirogabalin Besilate Tablets Revenue Market Share by Region (2027–2032)
Table 27. North America Mirogabalin Besilate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Mirogabalin Besilate Tablets Sales by Country (Units), 2021–2026
Table 29. North America Mirogabalin Besilate Tablets Sales by Country (Units), 2027–2032
Table 30. North America Mirogabalin Besilate Tablets Revenue by Country (US$ Million), 2021–2026
Table 31. North America Mirogabalin Besilate Tablets Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Mirogabalin Besilate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Mirogabalin Besilate Tablets Sales by Country (Units), 2021–2026
Table 34. Europe Mirogabalin Besilate Tablets Sales by Country (Units), 2027–2032
Table 35. Europe Mirogabalin Besilate Tablets Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Mirogabalin Besilate Tablets Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Mirogabalin Besilate Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Mirogabalin Besilate Tablets Sales by Region (Units), 2021–2026
Table 39. Asia Pacific Mirogabalin Besilate Tablets Sales by Region (Units), 2027–2032
Table 40. Asia Pacific Mirogabalin Besilate Tablets Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Mirogabalin Besilate Tablets Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Mirogabalin Besilate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Mirogabalin Besilate Tablets Sales by Country (Units), 2021–2026
Table 44. Latin America Mirogabalin Besilate Tablets Sales by Country (Units), 2027–2032
Table 45. Latin America Mirogabalin Besilate Tablets Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Mirogabalin Besilate Tablets Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Mirogabalin Besilate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Mirogabalin Besilate Tablets Sales by Country (Units), 2021–2026
Table 49. Middle East and Africa Mirogabalin Besilate Tablets Sales by Country (Units), 2027–2032
Table 50. Middle East and Africa Mirogabalin Besilate Tablets Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Mirogabalin Besilate Tablets Revenue by Country (US$ Million), 2027–2032
Table 52. Global Mirogabalin Besilate Tablets Sales (Units) by Type (2021–2026)
Table 53. Global Mirogabalin Besilate Tablets Sales (Units) by Type (2027–2032)
Table 54. Global Mirogabalin Besilate Tablets Sales Market Share by Type (2021–2026)
Table 55. Global Mirogabalin Besilate Tablets Sales Market Share by Type (2027–2032)
Table 56. Global Mirogabalin Besilate Tablets Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Mirogabalin Besilate Tablets Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Mirogabalin Besilate Tablets Revenue Market Share by Type (2021–2026)
Table 59. Global Mirogabalin Besilate Tablets Revenue Market Share by Type (2027–2032)
Table 60. Global Mirogabalin Besilate Tablets Price (US$/Unit) by Type (2021–2026)
Table 61. Global Mirogabalin Besilate Tablets Price (US$/Unit) by Type (2027–2032)
Table 62. Global Mirogabalin Besilate Tablets Sales (Units) by Application (2021–2026)
Table 63. Global Mirogabalin Besilate Tablets Sales (Units) by Application (2027–2032)
Table 64. Global Mirogabalin Besilate Tablets Sales Market Share by Application (2021–2026)
Table 65. Global Mirogabalin Besilate Tablets Sales Market Share by Application (2027–2032)
Table 66. Global Mirogabalin Besilate Tablets Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Mirogabalin Besilate Tablets Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Mirogabalin Besilate Tablets Revenue Market Share by Application (2021–2026)
Table 69. Global Mirogabalin Besilate Tablets Revenue Market Share by Application (2027–2032)
Table 70. Global Mirogabalin Besilate Tablets Price (US$/Unit) by Application (2021–2026)
Table 71. Global Mirogabalin Besilate Tablets Price (US$/Unit) by Application (2027–2032)
Table 72. Daiichi Sankyo Company Information
Table 73. Daiichi Sankyo Description and Business Overview
Table 74. Daiichi Sankyo Mirogabalin Besilate Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Daiichi Sankyo Mirogabalin Besilate Tablets Product
Table 76. Daiichi Sankyo Recent Developments/Updates
Table 77. Jiangsu Lianhuan Pharmaceutical Company Information
Table 78. Jiangsu Lianhuan Pharmaceutical Description and Business Overview
Table 79. Jiangsu Lianhuan Pharmaceutical Mirogabalin Besilate Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. Jiangsu Lianhuan Pharmaceutical Mirogabalin Besilate Tablets Product
Table 81. Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates
Table 82. Chongqing Huabang Pharmaceutical Company Information
Table 83. Chongqing Huabang Pharmaceutical Description and Business Overview
Table 84. Chongqing Huabang Pharmaceutical Mirogabalin Besilate Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. Chongqing Huabang Pharmaceutical Mirogabalin Besilate Tablets Product
Table 86. Chongqing Huabang Pharmaceutical Recent Developments/Updates
Table 87. Shandong Jingwei Pharmaceutical Company Information
Table 88. Shandong Jingwei Pharmaceutical Description and Business Overview
Table 89. Shandong Jingwei Pharmaceutical Mirogabalin Besilate Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. Shandong Jingwei Pharmaceutical Mirogabalin Besilate Tablets Product
Table 91. Shandong Jingwei Pharmaceutical Recent Developments/Updates
Table 92. Hainan Herui Pharmaceutical Company Information
Table 93. Hainan Herui Pharmaceutical Description and Business Overview
Table 94. Hainan Herui Pharmaceutical Mirogabalin Besilate Tablets Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. Hainan Herui Pharmaceutical Mirogabalin Besilate Tablets Product
Table 96. Hainan Herui Pharmaceutical Recent Developments/Updates
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Mirogabalin Besilate Tablets Distributors List
Table 100. Mirogabalin Besilate Tablets Customers List
Table 101. Mirogabalin Besilate Tablets Market Trends
Table 102. Mirogabalin Besilate Tablets Market Drivers
Table 103. Mirogabalin Besilate Tablets Market Challenges
Table 104. Mirogabalin Besilate Tablets Market Restraints
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Authors List of This Report
List of Figures
Figure 1. Product Picture of Mirogabalin Besilate Tablets
Figure 2. Global Mirogabalin Besilate Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Mirogabalin Besilate Tablets Market Share by Type: 2025 & 2032
Figure 4. 2.5mg Product Picture
Figure 5. 5mg Product Picture
Figure 6. Global Mirogabalin Besilate Tablets Market Value by Production Technology (US$ Million), 2021–2032
Figure 7. Global Mirogabalin Besilate Tablets Market Share by Production Technology: 2025 vs 2032
Figure 8. Original Product Picture
Figure 9. Generic Product Picture
Figure 10. Global Mirogabalin Besilate Tablets Market Value by Combination Therapy (US$ Million), 2021–2032
Figure 11. Global Mirogabalin Besilate Tablets Market Share by Combination Therapy: 2025 vs 2032
Figure 12. Mirogabalin Besylate + Mecobalamin Product Picture
Figure 13. Mirogabalin Besylate + Duloxetine Product Picture
Figure 14. Global Mirogabalin Besilate Tablets Market Value by Application (US$ Million), 2021–2032
Figure 15. Global Mirogabalin Besilate Tablets Market Share by Application: 2025 & 2032
Figure 16. Diabetic Peripheral Neuropathic Pain
Figure 17. Postherpetic Neuralgia
Figure 18. Fibromyalgia Syndrome
Figure 19. Others
Figure 20. Global Mirogabalin Besilate Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Mirogabalin Besilate Tablets Market Size (US$ Million), 2021–2032
Figure 22. Global Mirogabalin Besilate Tablets Sales (Units), 2021–2032
Figure 23. Global Mirogabalin Besilate Tablets Average Price (US$/Unit), 2021–2032
Figure 24. Mirogabalin Besilate Tablets Report Years Considered
Figure 25. Mirogabalin Besilate Tablets Sales Share by Manufacturers in 2025
Figure 26. Global Mirogabalin Besilate Tablets Revenue Share by Manufacturers in 2025
Figure 27. Top 5 and Top 10 Global Mirogabalin Besilate Tablets Players: Market Share by Revenue in Mirogabalin Besilate Tablets in 2025
Figure 28. Mirogabalin Besilate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 29. Global Mirogabalin Besilate Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 30. North America Mirogabalin Besilate Tablets Sales Market Share by Country (2021–2032)
Figure 31. North America Mirogabalin Besilate Tablets Revenue Market Share by Country (2021–2032)
Figure 32. United States Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Canada Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Europe Mirogabalin Besilate Tablets Sales Market Share by Country (2021–2032)
Figure 35. Europe Mirogabalin Besilate Tablets Revenue Market Share by Country (2021–2032)
Figure 36. Germany Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. France Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. U.K. Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Italy Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Russia Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Asia Pacific Mirogabalin Besilate Tablets Sales Market Share by Region (2021–2032)
Figure 42. Asia Pacific Mirogabalin Besilate Tablets Revenue Market Share by Region (2021–2032)
Figure 43. China Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Japan Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. South Korea Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. India Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Australia Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. China Taiwan Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Southeast Asia Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Latin America Mirogabalin Besilate Tablets Sales Market Share by Country (2021–2032)
Figure 51. Latin America Mirogabalin Besilate Tablets Revenue Market Share by Country (2021–2032)
Figure 52. Mexico Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Brazil Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Argentina Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Colombia Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Middle East and Africa Mirogabalin Besilate Tablets Sales Market Share by Country (2021–2032)
Figure 57. Middle East and Africa Mirogabalin Besilate Tablets Revenue Market Share by Country (2021–2032)
Figure 58. Turkey Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Saudi Arabia Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. UAE Mirogabalin Besilate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Global Sales Market Share of Mirogabalin Besilate Tablets by Type (2021–2032)
Figure 62. Global Revenue Market Share of Mirogabalin Besilate Tablets by Type (2021–2032)
Figure 63. Global Mirogabalin Besilate Tablets Price (US$/Unit) by Type (2021–2032)
Figure 64. Global Sales Market Share of Mirogabalin Besilate Tablets by Application (2021–2032)
Figure 65. Global Revenue Market Share of Mirogabalin Besilate Tablets by Application (2021–2032)
Figure 66. Global Mirogabalin Besilate Tablets Price (US$/Unit) by Application (2021–2032)
Figure 67. Mirogabalin Besilate Tablets Value Chain
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed